On Monday, Indivior Pharmaceuticals (NASDAQ: INDV) went out on a positive note, in a manner of speaking.
That's because the first trading session of November marked its last day as a stand-alone company and stock.
That morning, Indivior announced that its merger with peer Supernus Pharmaceuticals (NASDAQ: SUPN) had closed.